Cencora Stock Down Despite Q1 Earnings Beat, Gross Margin Improves

Key Takeaways COR reported Q1 adjusted EPS of $4.08, beating estimates, while revenue rose 5.5% year over year.Cencora saw 5% U.S. segment revenue growth driven by GLP-1 and specialty drug demand.COR expanded adjusted gross margin by 37 bps and raised FY26 revenue growth guidance to 7-9%.Cencora, Inc. (COR) reported fiscal first-quarter 2026adjusted earnings per share (EPS) of $4.08, which beat the Zacks Consensus Estimate of $4.07 by 0.2%. The bottom line also improved 9.4% year over year.GAAP EPS was $2.8 ...